ZS was recently named a Leader in R&D strategic consulting and a Major Player in R&D IT outsourcing (ITO) in two IDC MarketScape assessments that illuminate the competitive landscape for R&D consulting firms in the life sciences space.
“What makes ZS unique is that they are leading R&D digital transformation from the intersection of technology, data science and business”
“What makes ZS unique is that they are leading R&D digital transformation from the intersection of technology, data science and business,” notes the author of the IDC MarketScape for Strategic Consulting, Dr. Nimita Limaye, Research VP, Life Sciences R&D Strategy and Technology, at IDC Health Insights. Some of the strengths attributed to ZS in the two assessments include:
Top iTechnology IT and DevOps News: New York City Housing Authority Keeps “City Within a City” Safe and Informed with Everbridge
- Accelerators. ZS is seen as an analytical powerhouse, armed with a host of proprietary artificial intelligence (AI) and advanced analytics-based accelerators made for a range of R&D applications within life sciences.
- Solutions. To complement its collaborative, UX-focused engineering approach, ZS has built its solutions on a common-components framework (CCF) so they can ingest data from diverse sources and enable workbench flexibility.
- Expertise. ZS is differentiated by expertise in niche areas, including clinical study and budget management, integrated study design and feasibility, translational research strategy, medical affairs and real-world evidence.
- Innovation. ZS has built an advisory board of pharma leaders to help guide its strategy and remains focused on innovation: Over 50% of its ITO business is dedicated to innovation or intellectual property (IP) and one-fourth of its R&D ITO work is already AI-powered.
- People. ZS retains a large, experienced and skilled workforce with a deep understanding of R&D, and it recently made three acquisitions—Medullan, Braincase LLC and the assets of ZS Vista (formerly BASES Pharmaceutical Forecasting)—that will further enhance its products and offerings.
- Partnerships. ZS has cultivated a strategic partnership ecosystem with key digital platforms and data providers, allowing the firm to generate insights based on rich, multidimensional data.
Top iTechnology Security News: Asana Enterprise Work Graph: Helping the World’s Largest Organizations Achieve Clarity in Unclear Times
“ZS is investing significantly in innovative capabilities across the research and development life cycle,” noted Aaron Mitchell, ZS’s R&D Excellence practice leader. “These investments reflect our commitment to strategically partner with our clients on the discovery and development of innovative medicines that improve the lives of patients.”
For R&D strategic consulting, ZS was placed in the Leaders Category of the “IDC MarketScape: Worldwide Life Science R&D Strategic Consulting Services 2021 Assessment,” ¹ along with eight other vendors. In the “IDC MarketScape: Worldwide Life Science R&D ITO Services 2021 Vendor Assessment,” ² ZS was named a Major Player in a cohort of 11 ITO providers.
“ZS is honored by this recognition,” Aaron Mitchell reflected. “Acknowledgement in these MarketScapes is especially gratifying, knowing they are partly based on our clients’ feedback.”
Top iTechnology Networking News: Command The 5G Network VIAVI Introduces Industry’s First Field Test Instrument for O-RAN Deployment
[To share your insights with us, please write to sghosh@martechseries.com]
